LIGORIO, FRANCESCA

LIGORIO, FRANCESCA  

Universita' degli Studi di MILANO  

Mostra records
Risultati 1 - 14 di 14 (tempo di esecuzione: 0.002 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Case Report: Prolonged clinical benefit with sequential trastuzumab-containing treatments in a patient with advanced extramammary Paget disease of the groin 18-ago-2022 Zattarin, EmmaNichetti, FedericoLigorio, FrancescaMazzeo, LauraLobefaro, RiccardoFuca, GiovanniPeverelli, GiorgiaVingiani, Andreade Braud, FilippoVernieri, Claudio + Article (author) -
Efficacy and Safety of First-line Carboplatin-paclitaxel and Carboplatin-gemcitabine in Patients With Advanced Triple-negative Breast Cancer: A Monocentric, Retrospective Comparison 1-gen-2023 Ligorio F.Rametta A.Leporati R.Depretto C.Vingiani A.Pruneri G.de Braud F. + Article (author) -
Exceptional tumour responses to fasting-mimicking diet combined with standard anticancer therapies: A sub-analysis of the NCT03340935 trial 1-set-2022 Ligorio, FrancescaProvenzano, LeonardoLobefaro, RiccardoVingiani, AndreaPruneri, Giancarlode Braud, Filippo + Article (author) -
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications 1-gen-2020 Zattarin, ELeporati, RLigorio, FLobefaro, RVingiani, APruneri, GVernieri, C Article (author) -
Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients 1-gen-2021 Ligorio F.Zambelli L.Bottiglieri A.Zattarin E.Ottini A.Vingiani A.Pruneri G.de Braud F. + Article (author) -
Impact of baseline and on-treatment glycemia on everolimus-exemestane efficacy in patients with hormone receptor-positive advanced breast cancer (EVERMET) 1-gen-2021 Vernieri, ClaudioNichetti, FedericoMarra, AntonioRandon, GiovanniLigorio, FrancescaFerraro, EmanuelaTrapani, DarioMilani, AndreaBernocchi, OttaviaAjazi, ArtaGenerali, DanieleLosurdo, AgneseCurigliano, GiuseppePruneri, GiancarloMariani, Luigide Braud, Filippo + Article (author) -
Impact of pathological stratification on the clinical outcomes of advanced well‐differentiated/dedifferentiated liposarcoma treated with trabectedin 1-mar-2021 Fabbroni C.Ligorio F.Casali P. G.Sanfilippo R. + Article (author) -
Predictive role of CD36 expression in HER2-positive breast cancer patients receiving neoadjuvant trastuzumab 5-lug-2022 Ligorio, FrancescaVerderio, PaoloCiniselli, Chiara MauraCorsetto, Paola AntoniaLorenzini, DanieleVingiani, AndreaPruneri, GiancarloVernieri, Claudio + Article (author) -
Prognostic role of body mass index (BMI) in patients with Human Epidermal growth factor Receptor 2 (HER2)epositive early breast cancer treated with adjuvant trastuzumab-containing chemotherapy 1-set-2020 Ligorio, F.Zambelli, L.Bottiglieri, A.Castagnoli, L.Zattarin, E.Vingiani, A.Pruneri, G.de Braud, F.Vernieri, C. + Article (author) -
Prognostic significance of HER2-low status in HR-positive/HER2-negative advanced breast cancer treated with CDK4/6 inhibitors 1-gen-2023 Sposetti C.Leporati R.Corti C.Ligorio F.Provenzano L.Vingiani A.Sirico M.Zagami P.Boldrini L.Losurdo A.Criscitiello C.Curigliano G.Pruneri G.de Braud F. + Article (author) -
Prolonged benefit from palbociclib plus letrozole in heavily pretreated advanced male breast cancer: case report 1-dic-2021 Zattarin E.Ligorio F.Nichetti F.de Braud F. + Article (author) -
Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer 28-lug-2021 Ligorio F.Pellegrini I.Vingiani A.Lobefaro R.Zattarin E.Pruneri G.de Braud F. + Article (author) -
The pan-immune-inflammation-value predicts the survival of patients with human epidermal growth factor receptor 2 (Her2)—positive advanced breast cancer treated with first-line taxane-trastuzumab-pertuzumab 1-apr-2021 Ligorio F.Zattarin E.Lobefaro R.Zambelli L.Leporati R.de Braud F. + Article (author) -
Wave climate at shallow waters along the Abu Dhabi coast 1-gen-2018 Ligorio F.D'Alessandro F. + Article (author) -